Catalent Stock Beta
| 0C8 Stock | EUR 59.93 0.29 0.48% |
Catalent fundamentals help investors to digest information that contributes to Catalent's financial success or failures. It also enables traders to predict the movement of Catalent Stock. The fundamental analysis module provides a way to measure Catalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalent stock.
Catalent |
Catalent Company Beta Analysis
Catalent's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Catalent Beta | 1.26 |
Most of Catalent's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Catalent has a Beta of 1.2619. This is 46.73% higher than that of the Healthcare sector and 24.89% lower than that of the Drug Manufacturers - Specialty & Generic industry. The beta for all Germany stocks is notably lower than that of the firm.
Catalent Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.Catalent is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Catalent will likely underperform.
Catalent Fundamentals
| Return On Equity | 0.0873 | |||
| Return On Asset | 0.041 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 11.57 B | |||
| Shares Outstanding | 180.09 M | |||
| Shares Owned By Insiders | 0.36 % | |||
| Shares Owned By Institutions | 99.64 % | |||
| Price To Earning | 44.99 X | |||
| Price To Book | 1.76 X | |||
| Price To Sales | 1.57 X | |||
| Revenue | 4.83 B | |||
| Gross Profit | 1.64 B | |||
| EBITDA | 1.11 B | |||
| Net Income | 519 M | |||
| Cash And Equivalents | 227.9 M | |||
| Cash Per Share | 1.56 X | |||
| Total Debt | 4.17 B | |||
| Debt To Equity | 134.90 % | |||
| Current Ratio | 2.18 X | |||
| Book Value Per Share | 27.29 X | |||
| Cash Flow From Operations | 439 M | |||
| Earnings Per Share | 2.14 X | |||
| Price To Earnings To Growth | 1.17 X | |||
| Target Price | 150.92 | |||
| Number Of Employees | 19 K | |||
| Beta | 1.26 | |||
| Market Capitalization | 11.84 B | |||
| Total Asset | 10.51 B | |||
| Z Score | 1.2 | |||
| Net Asset | 10.51 B |
About Catalent Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Catalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Catalent Stock
When determining whether Catalent is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catalent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catalent Stock. Highlighted below are key reports to facilitate an investment decision about Catalent Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Catalent Stock please use our How to Invest in Catalent guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.